Halozyme Therapeutics reported $181.5M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Amarin USD 224M 15.41M Sep/2024
Amgen USD 6.58B 146M Jun/2025
Baxter International USD 2.17B 124M Mar/2025
Cytokinetics 0 0 Dec/2023
Eli Lilly USD 11.01B 1.7B Jun/2025
Halozyme Therapeutics USD 181.5M 16.64M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
MannKind USD 28.49M 401K Jun/2025
Pfizer USD 11.67B 817M Jun/2025
United Therapeutics USD 169.2M 3.8M Jun/2025